POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.

Congressional Hearing on the Costs of Public Company Compliance

Original title: THE COST OF BEING A PUBLIC COMPANY IN LIGHT OF SARBANES OXLEY AND THE FEDERALIZATION OF CORPORATE GOVERNANCE

Record date · January 1, 2018

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

The House Subcommittee on Capital Markets, Securities, and Investment held a hearing on July 18, 2017, to examine the financial and regulatory burdens placed on public companies by the and federal corporate governance standards. The session featured testimony from industry leaders, legal experts, and policy advocates regarding the impact of these regulations on market competitiveness.

Why it matters

This hearing explores whether current federal regulations for public companies create excessive costs that discourage businesses from going public, which directly impacts investment opportunities and the regulatory environment for U.S. capital markets.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Publicly traded companies

These entities are subject to the federal corporate governance and reporting requirements discussed in the hearing.

Indirectly affected

Investors

Changes to corporate governance regulations may alter the information available to investors and the costs associated with public market participation.

Key Facts

  • The hearing took place on July 18, 2017, in the Rayburn House Office Building.
  • The primary focus was the impact of the Sarbanes-Oxley Act on the costs of operating as a public company.
  • Witnesses included representatives from the NYSE, the U.S. Chamber of Commerce, academia, and the private sector.
  • The hearing record includes prepared statements from five expert witnesses and additional materials from the Depository Trust & Clearing Corporation and Institutional Shareholder Services Inc.

Frequently Asked Questions

What is the purpose of this hearing?
To review the costs and regulatory requirements imposed on public companies by federal law, specifically the .
Who testified at this hearing?
Experts from the New York Stock Exchange, the U.S. Chamber of Commerce, the Competitive Enterprise Institute, and the University of Denver Sturm College of Law, along with a finance executive from aTyr Pharma, Inc.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Regulatory Burden

The hearing highlights a legislative interest in 2017 in re-evaluating post-Enron era regulations to potentially reduce compliance costs for public companies.

Connected Entities

John Berlau, John Blake, Bill Huizenga and 4 more
PersonJohn Berlau“Senior Fellow at the Competitive Enterprise Institute.”Map →
PersonJohn Blake“Senior Vice President of Finance at aTyr Pharma, Inc.”Map →
PersonBill Huizenga“Chairman of the subcommittee.”Map →
OrganizationSubcommittee on Capital Markets, Securities, and Investment“The congressional body conducting the hearing.”Map →
PersonThomas Quaadman“Executive Vice President, Center for Capital Markets Competitiveness, U.S. Chamb”Map →
PersonThomas W. Farley“President of the New York Stock Exchange (NYSE).”Map →
PersonJ. Robert Brown, Jr.“Professor of Corporate Governance at University of Denver.”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record